The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Parkinson's Disease and the Environment
Open accessAbstract
Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder that affects an estimated 10 million sufferers worldwide. The two forms of PD include familial and sporadic, and while the etiology of PD is still largely unknown, the condition is likely to be multifactorial with genetic and environmental factors contributing to disease genesis. Diagnosis of the condition is attained through the observation of cardinal clinical manifestations including resting tremor, muscle rigidity, slowness or loss of movement, and postural instability. Unfortunately, by the time these features become apparent extensive neurological damage has already occurred. A cure for PD has not been identified and the current therapy options are pharmaceutical- and/or surgical-based interventions to treat condition symptoms. There is no specific test for PD and most diagnoses are confirmed by a combination of clinical symptoms and positive responses to dopaminergic drug therapies. The prevalence and incidence of PD vary worldwide influenced by several factors such as age, gender, ethnicity, genetic susceptibilities, and environmental exposures. Here, we will present environmental factors implicated in sporadic PD onset. By understanding the mechanisms in which environmental factors interact with, and affect the brain we can stride toward finding the underlying cause(s) of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Information bias in health research: definition, pitfalls, and adjustment methods
Althubaiti, A. (2016) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s104807 · Cited by 3,018
Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia.
Combs, C. A., Singh, N. B., & Khoury, J. C. (1993) · PubMed · Cited by 2,499
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Kasprzyk-Hordern, B., Dinsdale, R. M., & Guwy, A. J. (2009) · Water Research · doi:10.1016/j.watres.2008.10.047 · Cited by 1,678
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Szumilas, M. (2010) · PubMed · Cited by 1,136
Gene–environment interactions in human diseases
Hunter, D. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1578 · Cited by 1,132
Low dose mercury toxicity and human health
Zahir, F., Rizwi, S. J., Haq, S. K., & Khan, R. H. (2005) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2005.03.007 · Cited by 1,130
C ERULOPLASMIN M ETABOLISM AND F UNCTION
Hellman, N. E., & Gitlin, J. D. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.012502.114457 · Cited by 933
Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Bhat, A. H., Dar, K. B., Anees, S., Zargar, M. A., Masood, A., Sofi, M. A., & Ganie, S. A. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.07.025 · Cited by 928
de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alperovitch, A., & Rocca, W. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.10 · Cited by 833
A common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
Bollati, V, & Baccarelli, A. (2010) · Heredity · doi:10.1038/hdy.2010.2 · Cited by 590
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
Hirsch, L., Jette, N., Frolkis, A., Steeves, T., & Pringsheim, T. (2016) · Neuroepidemiology · doi:10.1159/000445751 · Cited by 571
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
Di Fonzo, A., Rohé, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17829-5 · Cited by 531
Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M. G., Reichmann, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008762 · Cited by 524
A comparison of concentrations of lead in human tissues.
Barry, P. S. (1975) · Occupational and Environmental Medicine · doi:10.1136/oem.32.2.119 · Cited by 506
Metabolism and functions of copper in brain
Scheiber, I. F., Mercer, J. F. B., & Dringen, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.002 · Cited by 506
Sex differences in Parkinson’s disease
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 489
Occupational exposures to metals as risk factors for Parkinson's disease
Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., Kortsha, G. X., Brown, G. G., & Richardson, R. J. (1997) · Neurology · doi:10.1212/wnl.48.3.650 · Cited by 476
Manganese‐Induced Parkinsonism and Parkinson's Disease
Olanow, C. W. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.018 · Cited by 468
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457
Toxic Effects of Mercury on the Cardiovascular and Central Nervous Systems
Fernandes Azevedo, B., Barros Furieri, L., Peçanha, F. M., Wiggers, G. A., Frizera Vassallo, P., Ronacher Simões, M., Fiorim, J., Rossi de Batista, P., Fioresi, M., Rossoni, L., et al. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/949048 · Cited by 455
Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates
Collier, T. J., Kanaan, N. M., & Kordower, J. H. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3039 · Cited by 449
Wright Willis, A., Evanoff, B. A., Lian, M., Criswell, S. R., & Racette, B. A. (2010) · Neuroepidemiology · doi:10.1159/000275491 · Cited by 436
Understanding the human health effects of chemical mixtures.
Carpenter, D. O., Arcaro, K., & Spink, D. C. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s125 · Cited by 424
Langston, J. W. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179006 · Cited by 424
Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features
Kwakye, G., Paoliello, M., Mukhopadhyay, S., Bowman, A., & Aschner, M. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120707519 · Cited by 372
Monte, D. A. D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00501-5 · Cited by 361
Genetics of Parkinson's disease
Lill, C. M. (2016) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2016.11.001 · Cited by 361
Parkinson’s disease risk from ambient exposure to pesticides
Wang, A., Costello, S., Cockburn, M., Zhang, X., Bronstein, J., & Ritz, B. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9574-5 · Cited by 349
Exposure to pesticides or solvents and risk of Parkinson disease
Pezzoli, G., & Cereda, E. (2013) · Neurology · doi:10.1212/wnl.0b013e318294b3c8 · Cited by 331
Postigo, C., López de Alda, M. J., & Barceló, D. (2010) · Environment International · doi:10.1016/j.envint.2009.10.004 · Cited by 328
Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study
Dick, F. D., De Palma, G., Ahmadi, A., Scott, N. W., Prescott, G. J., Bennett, J., Semple, S., Dick, S., Counsell, C., Mozzoni, P., et al. (2007) · Occupational and Environmental Medicine · doi:10.1136/oem.2006.027003 · Cited by 325
Professional exposure to pesticides and Parkinson disease
Elbaz, A., Clavel, J., Rathouz, P. J., Moisan, F., Galanaud, J., Delemotte, B., Alpérovitch, A., & Tzourio, C. (2009) · Annals of Neurology · doi:10.1002/ana.21717 · Cited by 317
Szewczyk-Krolikowski, K., Tomlinson, P., Nithi, K., Wade-Martins, R., Talbot, K., Ben-Shlomo, Y., & Hu, M. T. M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.025 · Cited by 294
Liu, B., Gao, H.-M., & Hong, J.-S. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6361 · Cited by 285
Pesticide exposure and risk of Parkinson's disease: A family-based case-control study
Hancock, D. B., Martin, E. R., Mayhew, G. M., Stajich, J. M., Jewett, R., Stacy, M. A., Scott, B. L., Vance, J. M., & Scott, W. K. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-6 · Cited by 285
Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair
Zárate, S., Stevnsner, T., & Gredilla, R. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00430 · Cited by 285
Amphetamine toxicities: Classical and emerging mechanisms
Yamamoto, B. K., Moszczynska, A., & Gudelsky, G. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05141.x · Cited by 279
Finkelstein, M. M., & Jerrett, M. (2007) · Environmental Research · doi:10.1016/j.envres.2007.03.002 · Cited by 277
Parkinson's disease: A test of the multifactorial etiologic hypothesis
Semchuk, K. M., Love, E. J., & Lee, R. G. (1993) · Neurology · doi:10.1212/wnl.43.6.1173 · Cited by 275
The genetic background of Parkinson's disease: current progress and future prospects
Kalinderi, K., Bostantjopoulou, S., & Fidani, L. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12563 · Cited by 273
Callaghan, R. C., Cunningham, J. K., Sykes, J., & Kish, S. J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.013 · Cited by 272
Occupation and Risk of Parkinsonism: A Multicenter Case-Control Study
Tanner, C. M., Ross, G. W., Jewell, S. A., Hauser, R. A., Jankovic, J., Factor, S. A., Bressman, S., Deligtisch, A., Marras, C., Lyons, K. E., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.195 · Cited by 267
Abuse of Amphetamines and Structural Abnormalities in the Brain
Berman, S., O'Neill, J., Fears, S., Bartzokis, G., & London, E. D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.031 · Cited by 253
Boleda, M. R., Galceran, M. T., & Ventura, F. (2009) · Water Research · doi:10.1016/j.watres.2008.11.056 · Cited by 243
The diagnosis of manganese-induced parkinsonism
Cersosimo, M. G., & Koller, W. C. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2005.10.006 · Cited by 234
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Verstraeten, A., Theuns, J., & Van Broeckhoven, C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.01.004 · Cited by 226
Huerta-Fontela, M., Galceran, M. T., & Ventura, F. (2008) · Environmental Science & Technology · doi:10.1021/es800768h · Cited by 218
García-García, C. R., Parrón, T., Requena, M., Alarcón, R., Tsatsakis, A. M., & Hernández, A. F. (2016) · Life Sciences · doi:10.1016/j.lfs.2015.10.013 · Cited by 217
Richardson, J. R., Caudle, W. M., Wang, M., Dean, E. D., Pennell, K. D., Miller, G. W., Richardson, J. R., Caudle, W. M., Wang, M., Dean, E. D., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5864fje · Cited by 216
Association of Cumulative Lead Exposure with Parkinson’s Disease
Weisskopf, M. G., Weuve, J., Nie, H., Saint-Hilaire, M.-H., Sudarsky, L., Simon, D. K., Hersh, B., Schwartz, J., Wright, R. O., & Hu, H. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002339 · Cited by 206
Dieldrin-Induced Neurotoxicity: Relevance to Parkinson's Disease Pathogenesis
Kanthasamy, A. G., Kitazawa, M., Kanthasamy, A., & Anantharam, V. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2004.07.010 · Cited by 201
Uversky, V. N., Li, J., Bower, K., & Fink, A. L. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00067-0 · Cited by 200
Traffic-Related Air Pollution and Parkinson’s Disease in Denmark: A Case–Control Study
Ritz, B., Lee, P.-C., Hansen, J., Lassen, C. F., Ketzel, M., Sørensen, M., & Raaschou-Nielsen, O. (2016) · Environmental Health Perspectives · doi:10.1289/ehp.1409313 · Cited by 194
Cannon, J. R., & Greenamyre, J. T. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.025 · Cited by 189
Sex differences in Parkinson's disease and other movement disorders
Smith, K. M., & Dahodwala, N. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.010 · Cited by 184
Curtin, K., Fleckenstein, A. E., Robison, R. J., Crookston, M. J., Smith, K. R., & Hanson, G. R. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.027 · Cited by 183
Involvement of Environmental Mercury and Lead in the Etiology of Neurodegenerative Diseases
Monnet-Tschudi, F., Zurich, M.-G., Boschat, C., Corbaz, A., & Honegger, P. (2006) · Reviews on Environmental Health · doi:10.1515/reveh.2006.21.2.105 · Cited by 176
Industrial toxicants and Parkinson's disease
Caudle, W. M., Guillot, T. S., Lazo, C. R., & Miller, G. W. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.010 · Cited by 175
Pesticide use in agriculture and Parkinson’s disease in the AGRICAN cohort study
Pouchieu, C., Piel, C., Carles, C., Gruber, A., Helmer, C., Tual, S., Marcotullio, E., Lebailly, P., & Baldi, I. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyx225 · Cited by 173
Genotype–Environment Interactions and Their Translational Implications
Baye, T. M., Abebe, T., & Wilke, R. A. (2010) · Personalized Medicine · doi:10.2217/pme.10.75 · Cited by 169
Thoughts on limitations of animal models
Härtung, T. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.003 · Cited by 166
Chinta, S. J., Lieu, C. A., DeMaria, M., Laberge, R. ‐., Campisi, J., & Andersen, J. K. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12029 · Cited by 165 · cited 1×
“Industrialized countries have higher urbanization leading to environmental degradation and exposure to environmental toxins (31).”
BackgroundGene–environment interactions: Key to unraveling the mystery of Parkinson's disease
Gao, H.-M., & Hong, J.-S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.03.005 · Cited by 165
The association between Parkinson's disease and melanoma
Pan, T., Li, X., & Jankovic, J. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.25912 · Cited by 164
Cocaine: Discussion on the Role of Dopamine in the Biochemical Mechanism of Action
Scheel-Krüger, J., Braestrup, C., Nielson, M., Golembiowska, K., & Mogilnicka, E. (1977) · Advances in Behavioral Biology · doi:10.1007/978-1-4684-3087-5_19 · Cited by 164
Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease
Coon, S., Stark, A., Peterson, E., Gloi, A., Kortsha, G., Pounds, J., Chettle, D., & Gorell, J. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9102 · Cited by 161
Willis, A. W., Evanoff, B. A., Lian, M., Galarza, A., Wegrzyn, A., Schootman, M., & Racette, B. A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq303 · Cited by 159
Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system
Hatcher-Martin, J. M., Richardson, J. R., Guillot, T. S., McCormack, A. L., Monte, D. A. D., Jones, D. P., Pennell, K. D., & Miller, G. W. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.020 · Cited by 156
The role of dopamine receptors in the neurotoxicity of methamphetamine
Ares‐Santos, S., Granado, N., & Moratalla, R. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12049 · Cited by 139
Guilarte, T. R., & Gonzales, K. K. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv099 · Cited by 136
Estimation of illicit drugs consumption by wastewater analysis in Paris area (France)
Karolak, S., Nefau, T., Bailly, E., Solgadi, A., & Levi, Y. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.04.007 · Cited by 130
Genetics of Parkinson’s Disease
Singleton, A., & Clarimón, J. (2007) · CRC Press eBooks · doi:10.3109/9781420019223-5 · Cited by 124
Lai, F. Y., Bruno, R., Hall, W., GARTNER, C. E., Ort, C., Kirkbride, K. P., Prichard, J., Thai, P. K., Carter, S., & Mueller, J. F. (2012) · Addiction · doi:10.1111/add.12006 · Cited by 121
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s disease
Popat, R. A., Eeden, S. K. V. D., Tanner, C. M., Kamel, F., Umbach, D. M., Marder, K. S., Mayeux, R. P., Ritz, B. R., Ross, G. W., Petrovitch, H., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03353.x · Cited by 119
Lai, F. Y., Thai, P. K., O'Brien, J. W., GARTNER, C. E., Bruno, R., Kele, B., Ort, C., Prichard, J., Kirkbride, K. P., Hall, W., et al. (2013) · Drug and Alcohol Review · doi:10.1111/dar.12061 · Cited by 118
Sex differences in Parkinson’s disease
Lubomski, M., Rushworth, R. L., Lee, W., Bertram, K., & Williams, D. R. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.12.016 · Cited by 117
D1 dopamine receptor: A putative neurochemical and behavioral link to cocaine action
Hummel, M., & Unterwald, E. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10078 · Cited by 110
Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling
Zhao, H., Wang, C., Zhao, N., Li, W., Yang, Z., Liu, X., Le, W., & Zhang, X. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.01.025 · Cited by 109
Parkinson's disease: Prevalence, diagnosis and impact.
Wong, S. L., Gilmour, H., & Ramage-Morin, P. L. (2014) · PubMed · Cited by 101
Mechanisms of Gene-Environment Interactions in Parkinson’s Disease
Fleming, S. M. (2017) · Current Environmental Health Reports · doi:10.1007/s40572-017-0143-2 · Cited by 101
Mechanism of copper(II)-induced misfolding of Parkinson's disease protein
Rose, F., Hodak, M., & Bernholc, J. (2011) · Scientific Reports · doi:10.1038/srep00011 · Cited by 88
Methamphetamine and Parkinson's Disease
Granado, N., Ares‐Santos, S., & Moratalla, R. (2013) · Parkinson s Disease · doi:10.1155/2013/308052 · Cited by 88
Is Methamphetamine Abuse a Risk Factor in Parkinsonism?
Guilarte, T. R. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(01)00046-8 · Cited by 84
Amphetamine exposure is elevated in Parkinson's disease
Garwood, E. R., Bekele, W., McCulloch, C. E., & Christine, C. W. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.03.015 · Cited by 83
Air pollution and Parkinson’s disease – evidence and future directions
Palacios, N. (2017) · Reviews on Environmental Health · doi:10.1515/reveh-2017-0009 · Cited by 83
Fe and Cu do not differ in Parkinson's disease: a replication study plus meta-analysis.
Mariani, S., Ventriglia, M., Simonelli, I., Donno, S., Bucossi, S., Vernieri, F., Melgari, J., Pasqualetti, P., Rossini, P., & Squitti, R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.015 · Cited by 73
Parkinson’s disease and occupational exposures: a systematic literature review and meta-analyses
Gunnarsson, L., & Bodin, L. (2017) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.3641 · Cited by 71
An, S. S. A., Kim, J., & Ankireddy, S. R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s88388 · Cited by 70
Paris, I. B., Perez-Pastene, C., Couve, E., Caviedes, P. A., LeDoux, S. P., & Segura‐Aguilar, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900323200 · Cited by 70
Diagnostic considerations in juvenile parkinsonism
Paviour, D. C., Surtees, R. A. H., & Lees, A. J. (2003) · Movement Disorders · doi:10.1002/mds.10644 · Cited by 69
Disrupted iron regulation in the brain and periphery in cocaine addiction
Ersche, K. D., Acosta‐Cabronero, J., Jones, P. S., Ziauddeen, H., van Swelm, R. P. L., Laarakkers, C. M., Raha‐Chowdhury, R., & Williams, G. B. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.271 · Cited by 69
Ubiquinone-quantum dot bioconjugates for in vitro and intracellular complex I sensing
Ma, W., Qin, L., Liu, F.-T., Gu, Z., Wang, J., Pan, Z. G., James, T. D., & Long, Y. (2013) · Scientific Reports · doi:10.1038/srep01537 · Cited by 64
Prevalence of Parkinson’s disease and atypical parkinsonian syndromes in a rural Japanese district
Osaki, Y., Morita, Y., Kuwahara, T., Miyano, I., & Doi, Y. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01442.x · Cited by 62
Occupational exposures and Parkinson's disease mortality in a prospective Dutch cohort
Brouwer, M., Koeman, T., van den Brandt, P. A., Kromhout, H., Schouten, L. J., Peters, S., Huss, A., & Vermeulen, R. C. H. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2014-102209 · Cited by 61
Epigenetic Biomarkers for Parkinson’s Disease: From Diagnostics to Therapeutics
Jakubowski, J. L., & Labrie, V. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160914 · Cited by 60
Shalash, A., Hamid, E., Elrassas, H. H., Bedair, A. S., Abushouk, A. I., Khamis, M., Hashim, M. A., Ahmed, N. S., Ashour, S., & Elbalkimy, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00357 · Cited by 60
Serum levels of zinc and copper in patients with Parkinson's disease
Jiménez‐Jiménez, F. J., Fernández–Calle, P., Martínez, M., Herrero, E., Molina, J. A., Vázquez, A., & Codoceo, R. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90127-7 · Cited by 59
Socioeconomic status in relation to Parkinson's disease risk and mortality
Fei, Y., Johansson, A. L. V., Pedersen, N. L., Fang, F., Gatz, M., & Wirdefeldt, K. (2016) · Medicine · doi:10.1097/md.0000000000004337 · Cited by 59
Illicit Stimulant Use Is Associated with Abnormal Substantia Nigra Morphology in Humans
Todd, G., Noyes, C., Flavel, S. C., Vedova, C. B. D., Spyropoulos, P., Chatterton, B. E., Berg, D., & White, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056438 · Cited by 58
Brito, J., McNeill, F. E., Webber, C. E., & Chettle, D. R. (2005) · Journal of Environmental Monitoring · doi:10.1039/b416054a · Cited by 56
Copper (Cu2+) induces degeneration of dopaminergic neurons in the nigrostriatal system of rats
Yu, W.-R., Jiang, H. F., Wang, J., & Xie, J. (2008) · Neuroscience Bulletin · doi:10.1007/s12264-008-0073-y · Cited by 55
Chen, C. C., Chen, T., Hwang, Y. C., Wen, Y. R., Chiu, Y. H., Wu, C. Y., Chen, R. C., Tai, J. J., Chen, T. H. H., & Liou, H. (2009) · Neuroepidemiology · doi:10.1159/000254572 · Cited by 55
EPIDEMIOLOGY OF PARKINSONISM IN VICTORIA
Jenkins, A. C. (1966) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1966.tb97295.x · Cited by 55
Morrow, B. A., Roth, R. H., Redmond, D. E., & Elsworth, J. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.046 · Cited by 53
Scorza, F. A., do Carmo, A. C., FIORINI, A. C., Nejm, M. B., Scorza, C. A., Finsterer, J., & Ferraz, H. B. (2017) · Clinics · doi:10.6061/clinics/2017(11)01 · Cited by 53
Dietary intake of iron, zinc, copper, and risk of Parkinson’s disease: a meta-analysis
Cheng, P., Jia, Y., Huang, W. C., Bai, S., Zhu, X., Qi, Z., Shao, W., & Xie, P. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2349-0 · Cited by 52
Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2
Chuang, Y., Lill, C. M., Lee, P., Hansen, J., Lassen, C. F., Bertram, L., Greene, N., Sinsheimer, J. S., & Ritz, B. R. (2016) · Neuroepidemiology · doi:10.1159/000450855 · Cited by 50
Prevalence of Parkinson’s disease in metropolitan and rural Queensland: A general practice survey
Peters, C. M., GARTNER, C. E., Silburn, P. A., & Mellick, G. D. (2006) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.04.015 · Cited by 42
Fukushima, T., Tan, X., Luo, Y., et al. (2011) · Neuroepidemiology · doi:10.1159/000328253 · Cited by 41
Kruse, N., Schulz‐Schaeffer, W., Schlossmacher, M. G., & Mollenhauer, B. (2012) · Methods · doi:10.1016/j.ymeth.2012.03.016 · Cited by 40
Drugs of abuse and Parkinson's disease
Mursaleen, L., & Stamford, J. A. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.013 · Cited by 33
The prevalence of Parkinson’s disease in a rural area of North-East England
Walker, R. W., Hand, A., Jones, C., Wood, B. H., & Gray, W. K. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.07.002 · Cited by 31
Elbaz, A., & Moisan, F. (2015) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2015-205455 · Cited by 29
Increase of Reproductive Life Span Delays Age of Onset of Parkinson’s Disease
Frentzel, D., Judanin, G., Borozdina, O., Klucken, J., Winkler, J., & Schlachetzki, J. C. M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00397 · Cited by 29
Cruces‐Sande, A., Méndez‐Álvarez, E., & Soto‐Otero, R. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14019 · Cited by 27
On the Role of Mining Exposure in Epigenetic Effects in Parkinson’s Disease
Castillo, S., Muñoz, P., Behrens, M. I., Díaz-Grez, F., & Segura‐Aguilar, J. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9736-7 · Cited by 19
Assessing of plasma levels of iron, zinc and copper in Iranian Parkinson's disease
Meamar, R., Nikyar, H., Dehghani, L., Basiri, K., & Ghazvini, M. R. A. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.178788 · Cited by 13
Cited by
Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 700
Peng, B., Yang, Q., B Joshi, R., Liu, Y., Akbar, M., Song, B.-J., Zhou, S., & Wang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072316 · Cited by 156
Nuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Hendy, A., Teo, W.-P., & Macpherson, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.003 · Cited by 103
Self-citationAmin, R., Quispe, C., Docea, A. O., Ydyrys, A., Kulbayeva, M., Durna Daştan, S., Calina, D., & Sharifi-Rad, J. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105376 · Cited by 74
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69
Metadata
- Authors
- Ball, N., Teo, W.-P., Chandra, S., & Chapman, J.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2019-03-19
- Volume
- 10
- Pages
- 218-218
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2924267298
- Cited by
- 480
- References
- 122
- FWCI
- 29.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.